Skip to main content

Quotient Bioresearch to Buy Three Thermo Fisher Orbitraps

NEW YORK (GenomeWeb news) – Quotient Bioresearch said today that it will buy three mass spectrometers from Thermo Fisher Scientific.
Cambridge, UK-based Quotient Bioresearch will use the three new LTQ Orbitrap XL mass spectrometers for use in its drug development and sports testing services.
The company said the new tools are part of its program to continue to develop its metabolite identification services, in part because the US Food and Drug Administration is “driving the need to identify and quantitate key metabolites at the early stage of the drug development process.”
The TFS mass spectrometers support small-molecule metabolite profiling and will enable Quotient Bioresearch to extract metabolite information from early toxicology and clinical research samples.
Financial terms of the agreement were not released.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.